Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 24 December 2004: Vol. 306. no. 5705, pp. 2267 - 2270 DOI: 10.1126/science.1103233
|
|
Reports
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
Eric O'Neill,1
Linda Rushworth,1
Manuela Baccarini,3
Walter Kolch1,2*
The ablation of the protein kinase Raf-1 renders cells hypersensitive to apoptosis despite normal regulation of extracellular signalregulated kinases, which suggests that apoptosis protection is mediated by a distinct pathway. We used proteomic analysis of Raf-1 signaling complexes to show that Raf-1 counteracts apoptosis by suppressing the activation of mammalian sterile 20like kinase (MST2). Raf-1 prevents dimerization and phosphorylation of the activation loop of MST2 independently of its protein kinase activity. Depletion of MST2 from Raf-1 / mouse or human cells abrogated sensitivity to apoptosis, whereas overexpression of MST2 induced apoptosis. Conversely, depletion of Raf-1 from Raf-1 +/+ mouse or human cells led to MST2 activation and apoptosis. The concomitant depletion of both Raf-1 and MST2 prevented apoptosis.
1 The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
2 Sir Henry Wellcome Functional Genomics Facility, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
3 Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Microbiology and Genetics, University of Vienna, Dr. Bohr Gasse 9, A-1030 Vienna, Austria.
* To whom correspondence should be addressed. E-mail: wkolch{at}beatson.gla.ac.uk
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP).
- T. Oka, V. Mazack, and M. Sudol (2008)
J. Biol. Chem.
283, 27534-27546
| Abstract »
| Full Text »
| PDF »
- BRAF V600E Disrupts AZD6244-Induced Abrogation of Negative Feedback Pathways between Extracellular Signal-Regulated Kinase and Raf Proteins.
- B. B. Friday, C. Yu, G. K. Dy, P. D. Smith, L. Wang, S. N. Thibodeau, and A. A. Adjei (2008)
Cancer Res.
68, 6145-6153
| Abstract »
| Full Text »
| PDF »
- Raf Signaling but not the ERK Effector SAP-1 Is Required for Regulatory T Cell Development.
- J. E. Willoughby, P. S. Costello, R. H. Nicolas, N. J. Robinson, G. Stamp, F. Powrie, and R. Treisman (2007)
J. Immunol.
179, 6836-6844
| Abstract »
| Full Text »
| PDF »
- Mitogen-Activated Protein Kinases in Heart Development and Diseases.
- Y. Wang (2007)
Circulation
116, 1413-1423
| Abstract »
| Full Text »
| PDF »
- Caspase-dependent Cleavage Disrupts the ERK Cascade Scaffolding Function of KSR1.
- M. M. McKay and D. K. Morrison (2007)
J. Biol. Chem.
282, 26225-26234
| Abstract »
| Full Text »
| PDF »
- Dissection of a Signaling Pathway by Which Pathogen-associated Molecular Patterns Recruit the JNK and p38 MAPKs and Trigger Cytokine Release.
- J. Zhong and J. M. Kyriakis (2007)
J. Biol. Chem.
282, 24246-24254
| Abstract »
| Full Text »
| PDF »
- Grb10 and Active Raf-1 Kinase Promote Bad-dependent Cell Survival.
- S. Kebache, J. Ash, M. G. Annis, J. Hagan, M. Huber, J. Hassard, C. L. Stewart, M. Whiteway, and A. Nantel (2007)
J. Biol. Chem.
282, 21873-21883
| Abstract »
| Full Text »
| PDF »
- Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5.
- L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, S. Wilhelm, M. Lynch, and C. Carter (2006)
Cancer Res.
66, 11851-11858
| Abstract »
| Full Text »
| PDF »
- Inhibition of Cell Migration by Autophosphorylated Mammalian Sterile 20-Like Kinase 3 (MST3) Involves Paxillin and Protein-tyrosine Phosphatase-PEST.
- T.-J. Lu, W.-Y. Lai, C.-Y. F. Huang, W.-J. Hsieh, J.-S. Yu, Y.-J. Hsieh, W.-T. Chang, T.-H. Leu, W.-C. Chang, W.-J. Chuang, et al. (2006)
J. Biol. Chem.
281, 38405-38417
| Abstract »
| Full Text »
| PDF »
- A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation.
- C. Rubiolo, D. Piazzolla, K. Meissl, H. Beug, J. C. Huber, A. Kolbus, and M. Baccarini (2006)
Blood
108, 152-159
| Abstract »
| Full Text »
| PDF »
- Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma..
- D. J. Panka, M. B. Atkins, and J. W. Mier (2006)
Clin. Cancer Res.
12, 2371s-2375s
| Abstract »
| Full Text »
| PDF »
- Regulation and role of raf-1/b-raf heterodimerization..
- L. K. Rushworth, A. D. Hindley, E. O'Neill, and W. Kolch (2006)
Mol. Cell. Biol.
26, 2262-2272
| Abstract »
| Full Text »
| PDF »
- Role of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis..
- H. J. Oh, K.-K. Lee, S. J. Song, M. S. Jin, M. S. Song, J. H. Lee, C. R. Im, J.-O. Lee, S. Yonehara, and D.-S. Lim (2006)
Cancer Res.
66, 2562-2569
| Abstract »
| Full Text »
| PDF »
- The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells.
- D. J. Panka, W. Wang, M. B. Atkins, and J. W. Mier (2006)
Cancer Res.
66, 1611-1619
| Abstract »
| Full Text »
| PDF »
- Raf-1 sets the threshold of Fas sensitivity by modulating Rok-{alpha} signaling.
- D. Piazzolla, K. Meissl, L. Kucerova, C. Rubiolo, and M. Baccarini (2005)
J. Cell Biol.
171, 1013-1022
| Abstract »
| Full Text »
| PDF »
- Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity.
- J. An and M. B. Rettig (2005)
Mol. Cell. Biol.
25, 7546-7556
| Abstract »
| Full Text »
| PDF »
- Mammalian Sterile 20-Like Kinases in Tumor Suppression: An Emerging Pathway.
- E. E. O'Neill, D. Matallanas, and W. Kolch (2005)
Cancer Res.
65, 5485-5487
| Abstract »
| Full Text »
| PDF »
|
|